The Commission received a request for a partial interim review (‘the review request’) pursuant to Article 19 and Article 23(6) of the basic Regulation.

The review request was lodged by DSM Nutritional Products Canada Inc. (‘the applicant’), an exporting producer from Canada, and was limited in scope to the possibility of obtaining an exemption from the extended measures.

In the review request the applicant claimed that it is a genuine producer of the product under review able to produce the entire quantity that it has shipped to the Union since the start of the investigation period of the anti-circumvention investigation mentioned in recital 2 leading to the imposition of the existing extended measures.

Furthermore, the applicant alleged that it was not related to any exporting producers subject to the measures in force, and that it was not circumventing the measures in force.

The Commission determined that the review request contained sufficient prima facie evidence to justify the initiation of a partial interim review pursuant to Article 19 and Article 23(6) of the basic Regulation. The Commission thus initiated on 19 May 2015 an investigation by a notice published in the Official Journal of the European Union (‘the notice of initiation’).

The product under review is fatty-acid mono-alkyl esters and/or paraffinic gasoil obtained from synthesis and/or hydro-treatment, of non-fossil origin, commonly known as ‘biodiesel’, in pure form or in a blend containing by weight more than 20 % of fatty-acid mono-alkyl esters and/or paraffinic gasoil obtained from synthesis and/or hydro-treatment, of non-fossil origin (‘the product under review’, or ‘biodiesel’), currently falling within CN codes ex 1516 20 98, ex 1518 00 91, ex 1518 00 99, ex 2710 19 43, ex 2710 19 46, ex 2710 19 47, ex 2710 20 11, ex 2710 20 15, ex 2710 20 17, ex 3824 90 92, ex 3826 00 10 and ex 3826 00 90 originating in the United States of America.

The reporting period for this investigation covered the period from 1 April 2014 to 31 March 2015 (‘reporting period’). Data was also collected from 1 April 2009 to the end of the reporting period.

The Commission officially informed the applicant and the representatives of Canada about the initiation of the partial interim review. Interested parties were given the opportunity to make their views known in writing and to request a hearing within the time limit set in the notice of initiation. Only the applicant came forward. No hearing was requested.

The Commission received the questionnaire reply submitted by the applicant, which was verified on the spot at the applicant's premises in Canada.

The applicant was founded in 1997 as a manufacturer of Omega 3 nutritional supplements.

The investigation established that the applicant is a genuine producer of biodiesel, which is resulting as a by-product from its manufacturing process of Omega 3 fish oil concentrates, its core business.

The investigation also confirmed that the applicant is not related to any producer of biodiesel located in the United States of America subject to measures.

The investigation furthermore confirmed that the biodiesel exported to the Union market was indeed produced by the applicant.

Moreover, the investigation did not reveal any evidence that the applicant purchased biodiesel from the United States of America, nor that it transhipped US manufactured biodiesel into the Union.

In view of the findings in recitals 14 to 18, the Commission established that the applicant is a genuine producer of the product under review, and that it therefore should be exempted from the extended measures.

Interested parties were informed of the intention to grant the exemption to the applicant and were given the opportunity to comment. No comments which could alter the decision to terminate the review investigation were received.

The measures provided for in this Regulation are in accordance with the opinion of the Committee established by Article 15(1) of Council Regulation (EC) No 1225/2009,